14. August 2017
The potential for use of polymers in controlled drug delivery systems has been long recognized. Since their appearance in the literature, a wide range of degradable and non-degradable polymers have been demonstrated in drug delivery devices.
19. September 2016
Improving drug delivery to the eye with Celanese EVA polymers DALLAS and BOSTON, Mass. (September 15, 2016) – Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present “Driving Ophthalmic Drug Delivery Innovation with EVA” on Tuesday, September 20 at the 2016 Targeting Ocular Disorders Conference in Boston, Mass. “Celanese is working with its customers to develop state-of-the-art drug delivery systems using our pharmaceutical material...
30. June 2016
VITALDOSE® EVA—AN EFFECTIVE DRUG DELIVERY TECHNOLOGY Our custom controlled release ethylene vinyl acetate, VitalDose® EVA, is improving pharmaceutical drug delivery applications around the world. VitalDose EVA is safe and dependable, and has performed effectively in controlled release applications for more than 20 years. Attend our technical presentation to see how our controlled release EVA is improving drug delivery technology. Join us at the 2016 Controlled Release Society (CRS) Annual...
18. June 2015
Formulation challenges are often associated with protein delivery vehicles, and controlled-release strategies that deliver medications locally are believed to offer some advantages. Most biologic formulations are made for a parenteral route of administration, but novel approaches, such as the use of microcellular foams, are being developed to enhance administration profiles and patient compliance. More